WuXi PharmaTech Schedules Third-Quarter 2012 Earnings Release

15 Oct, 2012, 12:35 ET from WuXi PharmaTech (Cayman) Inc.

SHANGHAI, Oct. 15, 2012 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the third quarter of 2012 after the New York Stock Exchange closes on Monday, November 12, 2012 (which will be Tuesday morning, November 13, 2012 Shanghai time). The earnings release will be available on the investor relations section of the Company's website at http://www.wuxiapptec.com/.

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, November 13, 2012, to discuss the third-quarter 2012 financial results and recent business activities. The conference call may be accessed by calling:

United States:  1-866-519-4004 China (Landline):  800-819-0121 China (Mobile):  400-620-8038 Hong Kong:  800-930-346 United Kingdom:  0-808-234-6646 International:  +65-6723-9381 Conference ID:  46119921

A telephone replay will be available two hours after the call's completion at:

United States:  1-866-214-5335 China North:  10-800-714-0386 China South:  10-800-140-0386 Hong Kong:  800-901-596 United Kingdom:  0-800-731-7846 International:  +61-2-8235-5000 Conference ID:  46119921

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com/.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

For more information, please contact:

Ronald Aldridge Director of Investor Relations WuXi PharmaTech (Cayman) Inc. Tel: +1-201-585-2048 Email: Ron_Aldridge@wuxiapptec.com Web: http://www.wuxiapptec.com

 

 

SOURCE WuXi PharmaTech (Cayman) Inc.



RELATED LINKS

http://www.wuxiapptec.com